Some patients aren't good candidates for an INVO™ cycle at Effortless IVF, including those suffering from severe male factor infertility and women with high levels of anti-müllerian hormone (AMH). Patients with an elevated AMH level typically require constant, expensive monitoring. Because the goal of Effortless IVF is to provide patients with a low-cost and less time-consuming method of treatment, these patients may be better candidates for a different type of ART.
Now I don't know if this covers all the scenarios that traditional IVF addresses. They also mention they do not offer certain fertility-related services and Effortless doesn't provide some of them so you would need to go elsewhere for that. At that point a couple may choose to do everything at an IVF clinic rather than piece meal the process. Who really knows?
Also as DFF mentioned it will take time for INVOcell to be an option that a doctor can offer. It takes time for new procedures to grab hold and the sense was that it is already happening which I think is not representative at all. They are just scratching the surface imo.
However, I do agree that if/when INVOcell is accepted as an approved treatment option for infertility by Insurance companies, it will be a great day for INVO Bio.
News 
Market Data 
Discover 
AI
